Sterling Johnson joins Ethics Talk to discuss his article, coauthored with Dr Kimberly L. Sue: "Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies.”
Dr Elizabeth Salisbury-Afshar joins Ethics Talk to discuss her article, coauthored with Drs Catherine J. Livingston and Ricky N. Bluthenthal: “How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder?”
Dr Ellen L. Edens joins Ethics Talk to discuss her article, coauthored with Drs Gabriela Garcia Vassallo and Robert Heimer: "How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice?”
Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?”
The increasing application of pharmacogenomics will signal a need for major policy changes that address ways to maintain patient confidentiality and make the technology available to all members of society.
A U.S. physician relates the culture shock he is experiencing working as an area medical officer in Eastern Africa for the U.S. Peace Corps in his latest online journal entry.
An ethical case that was eventually decided in the US Supreme Court involves the right of patients to request an independent third-party review if their HMO refuses to authorize treatments or procedures deemed medically necessary.